Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Elephantiasis Neuromatosis

fluorodeoxyglucose f18 has been researched along with Elephantiasis Neuromatosis in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's6 (66.67)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Ikuta, K; Imagama, S; Ito, K; Ito, S; Koike, H; Nishida, Y; Sakai, T; Urakawa, H1
Amann, G; Aszmann, O; Azizi, AA; Benkoe, TM; Hacker, M; Happak, W; Hojreh, A; Kasprian, G; Peyrl, A; Rausch, I; Slavc, I; Staudenherz, A; Theisen, BE; Traub-Weidinger, T; Wadsak, W; Weber, M1
Howman-Giles, R; London, K; Moharir, M; North, K1
Amrami, KK; Esther, RJ; Lowe, VJ; Shahid, KR; Spinner, RJ1
Drubach, L; Fahey, F; Irons, M; Tsai, LL; Ullrich, NJ; Voss, S1
Baldwin, A; Derdak, J; Dombi, E; Gillespie, A; Kurwa, A; Meany, H; Reynolds, J; Salzer, W; Tsokos, M; Whatley, M; Widemann, B1
Derlin, T; Friedrich, RE; Gawad, K; Hagel, C; Zustin, J1
Calonje, E; Ferner, RE; Golding, JF; Jan, W; O'Doherty, M; Sanjayanathan, V; Smith, M1
Alavi, A; Basu, S; Cnaan, A; Dombi, E; Fisher, MJ; Phillips, PC; Pollock, AN; Widemann, BC; Yu, JQ; Zhuang, H1

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Elephantiasis Neuromatosis

ArticleYear
Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [
    Pediatric blood & cancer, 2018, Volume: 65, Issue:1

    Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography

2018

Other Studies

8 other study(ies) available for fluorodeoxyglucose f18 and Elephantiasis Neuromatosis

ArticleYear
Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study.
    Cancer science, 2021, Volume: 112, Issue:3

    Topics: Adolescent; Adult; Aged; Carcinogenesis; Child; Cross-Sectional Studies; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; ROC Curve; Young Adult

2021
Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1.
    European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:7

    Topics: Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Neurofibroma, Plexiform; Neurofibromatosis 1; Optic Nerve Glioma; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed

2010
False-negative fluorine-18 fluorodeoxyglucose positron emission tomography of a malignant peripheral nerve sheath tumor arising from a plexiform neurofibroma in the setting of neurofibromatosis type 1.
    Journal of surgical orthopaedic advances, 2011,Summer, Volume: 20, Issue:2

    Topics: Adult; Diagnosis, Differential; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals

2011
[18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation.
    Journal of neuro-oncology, 2012, Volume: 108, Issue:3

    Topics: Adolescent; Adult; Cell Transformation, Neoplastic; Child; Child, Preschool; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Young Adult

2012
18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST).
    Pediatric blood & cancer, 2013, Volume: 60, Issue:1

    Topics: Adolescent; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals

2013
Surgery for atypical plexiform neurofibromas of the trunk in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin: a long-term follow-up.
    Anticancer research, 2012, Volume: 32, Issue:10

    Topics: Biomarkers, Tumor; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ki-67 Antigen; Membrane Glycoproteins; Mucin-1; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; S100 Proteins; Young Adult

2012
[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:2

    Topics: Adolescent; Adult; Age Factors; Aged; Biopsy, Needle; Child; Child, Preschool; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Probability; Risk Assessment; Sensitivity and Specificity; Sex Factors; Tomography, X-Ray Computed

2008
The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression.
    Journal of neuro-oncology, 2008, Volume: 87, Issue:2

    Topics: Adolescent; Adult; Child; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Neurofibroma, Plexiform; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals

2008